Physician profile
Andrew Reese
NPI 1861489312
$6,973.27
in general payments reported to CMS, 2019-2025
43 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,601 · 2020: $1,352 · 2021: $1,201 · 2023: $749 · 2024: $1,008 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,819.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,188.91 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $957.51 | 2019-2025 | |
| Novo Nordisk INC | $601.72 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $521.35 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Janssen Pharmaceuticals, INC | $252.76 | 2019-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.77 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $231.75 | 2019-2025 | |
| Exact Sciences Corporation | $231.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $223.96 | 2019-2021 | |
| Abbott Laboratories | $208.41 | 2019-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $208.33 | 2019-2024 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $200.82 | 2019-2025 | Gardasil 9, Vaxelis, Rotateq |
| Amgen INC. | $197.62 | 2019-2024 | Otezla, Repatha, Evenity |
| Astellas Pharma US INC | $183.30 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $181.29 | 2023-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.